LivingGLP1
Study S000851

Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

Registration

Registration
NCT03743025
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
TERMINATED
Enrollment
28
Start
2019-03-08
Primary completion
2023-05-02
Lead sponsor
Emory University
Conditions
Stress Hyperglycemia
Interventions
DRUG:Dulaglutide Injection; OTHER:Saline Injection
Results posted
TRUE
Individual participant data sharing
NO
Secondary identifiers
NIH:1K23GM128221-01A1

Registered primary outcomes

  • Number of Participants With Blood Glucose Levels (BG) > 140 mg/dl During Post Operative Period [During the hospital stay (up to 12 days postoperatively)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.